Gentian Diagnostics ASA (GENT.OL)

NOK 39.0

(0.0%)

Revenue Summary of Gentian Diagnostics ASA

Gentian Diagnostics ASA's latest annual revenue in 2023 was 136.19 Million NOK , up 32.98% from previous year.
Gentian Diagnostics ASA's latest quarterly revenue in 2024 Q2 was 38.25 Million NOK , down -0.63% from previous quarter.
Gentian Diagnostics ASA reported a annual revenue of 101.63 Million NOK in annual revenue 2022, up 22.27% from previous year.
Gentian Diagnostics ASA reported a annual revenue of 83.12 Million NOK in annual revenue 2021, up 21.58% from previous year.
Gentian Diagnostics ASA reported a quarterly revenue of 32.69 Million NOK for 2024 Q3, down -14.53% from previous quarter.
Gentian Diagnostics ASA reported a quarterly revenue of 38.5 Million NOK for 2024 Q1, up 2.77% from previous quarter.

Annual Revenue Chart of Gentian Diagnostics ASA (2023 - 2013)

Historical Annual Revenue of Gentian Diagnostics ASA (2023 - 2013)

Year	Revenue	Revenue Growth
2023	136.19 Million NOK	32.98%
2022	101.63 Million NOK	22.27%
2021	83.12 Million NOK	21.58%
2020	68.36 Million NOK	42.58%
2019	47.95 Million NOK	4.0%
2018	46.1 Million NOK	31.78%
2017	34.98 Million NOK	13.24%
2016	30.89 Million NOK	20.75%
2015	25.58 Million NOK	4.21%
2014	24.55 Million NOK	7.25%
2013	22.89 Million NOK	0.0%

Year	Revenue	Revenue Growth
2024 Q2	38.25 Million NOK	-0.63%
2024 Q3	32.69 Million NOK	-14.53%
2024 Q1	38.5 Million NOK	2.77%
2023 Q4	37.46 Million NOK	13.66%
2023 FY	135.15 Million NOK	32.98%
2023 Q1	31.43 Million NOK	12.63%
2023 Q3	32.96 Million NOK	-3.56%
2023 Q2	34.17 Million NOK	8.72%
2022 Q3	23.07 Million NOK	-23.34%
2022 Q1	20.55 Million NOK	-5.41%
2022 FY	101.63 Million NOK	22.27%
2022 Q4	27.91 Million NOK	20.98%
2022 Q2	30.09 Million NOK	46.39%
2021 Q3	17.17 Million NOK	-30.08%
2021 FY	83.12 Million NOK	21.58%
2021 Q2	24.56 Million NOK	1.51%
2021 Q1	24.2 Million NOK	82.0%
2021 Q4	21.73 Million NOK	26.52%
2020 Q2	19.87 Million NOK	3.9%
2020 Q1	19.13 Million NOK	110.05%
2020 FY	68.36 Million NOK	42.58%
2020 Q4	13.29 Million NOK	-17.2%
2020 Q3	16.06 Million NOK	-19.2%
2019 FY	47.95 Million NOK	4.0%
2019 Q4	9.1 Million NOK	-37.91%
2019 Q3	14.66 Million NOK	21.1%
2019 Q1	12.06 Million NOK	28.83%
2019 Q2	12.11 Million NOK	0.41%
2018 Q4	9.36 Million NOK	-44.85%
2018 FY	46.1 Million NOK	31.78%
2018 Q1	10.24 Million NOK	-20.26%
2018 Q2	9.52 Million NOK	-6.97%
2018 Q3	16.97 Million NOK	78.21%
2017 Q4	12.84 Million NOK	76.56%
2017 Q2	9.36 Million NOK	69.99%
2017 Q1	5.5 Million NOK	-51.29%
2017 FY	34.98 Million NOK	13.24%
2017 Q3	7.27 Million NOK	-22.31%
2016 Q4	11.3 Million NOK	119.04%
2016 Q2	8.23 Million NOK	28.22%
2016 Q1	6.42 Million NOK	-23.1%
2016 FY	30.89 Million NOK	20.75%
2016 Q3	5.16 Million NOK	-37.34%
2015 FY	25.58 Million NOK	4.21%
2015 Q3	5.11 Million NOK	0.0%
2015 Q4	8.35 Million NOK	63.28%
2014 FY	24.55 Million NOK	7.25%
2013 FY	22.89 Million NOK	0.0%

Peer Revenue Comparison of Gentian Diagnostics ASA

Name	Revenue	Revenue Difference
Lifecare AS	13.08 Million NOK	-940.74%
Medistim ASA	521.1 Million NOK	73.865%